Treatment outcomes of drug resistant tuberculosis patients in Morocco: multi-centric prospective study

Abstract

Background Drug resistant tuberculosis is a major public health problem in Morocco and worldwide. Treatment outcome of drug resistant tuberculosis is poor and requires a long period of treatment with many toxic and expensive antituberculosis drugs. The aim of this study is to evaluate treatment outcomes of drug resistant tuberculosis and to determine predictors of poor treatment outcomes in a large region of Morocco. Methods It is a multi-centric observational cohort study conducted from January 01, 2014 to January 01, 2016. A questionnaire was established to collect data from clinical charts of patients with confirmed resistant TB. The study was carried out in all the 11 centers located in the Rabat-Salé-Kénitra region of Morocco where drug resistant tuberculosis is treated. Treatment outcomes were reported and the definitions and classifications of these outcomes were defined according to the WHO guidelines. Univariate and multivariate logistic regression were conducted to determine factors associated with poor drug resistant tuberculosis treatment outcomes in Morocco. Results In our study, 101 patients were treated for drug resistant tuberculosis between January 01, 2014 and January 01, 2016. Patients’ age ranged from 9.5 to70 years; 72patients (71.3%) were male and 80 patients (79.2%) were living in urban areas. Thirty two patients were smokers, 74 patients had multidrug-resistant tuberculosis, 25 patients had rifampicin resistance and 2 patients had isoniazid resistance. Treatment outcomes of tuberculosis patients were as follows: 45 patients were cured (44.5%), 9 completed treatment (8.9%), 5 patients died before completing the treatment, 35 patients were lost to follow up (34.6%) and 7 patients had treatment failure. In the multivariate analysis, being a smoker is an independent risk factor for poor treatment outcomes, ( p -value = 0.015, OR = 4.355, IC [1.327–14.292]). Conclusion Treatment success outcomes occurred in more than half of the cases, which is lower than the World Health Organization target of at least a 75% success rate. A significant number of patients abandoned their treatment before its completion. These dropouts are a serious public health hazard that needs to be addressed urgently.

Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study

“…This is similar to other study findings [ 23 , 25 , 35 ]. Cigarette smoking directly causes ciliary dysfunction; this diminishes the immunity of individuals, which makes them prone to primary MDR-TB [ 56 , 57 ].…”

Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis Isolates from Moroccan Patients: Systematic Review

“…Tuberculosis (TB) strains that are resistant to the first-line TB treatment regimens are more difficult to treat than drug-susceptible ones [ 32 ], entails extended chemotherapy (up to 2 years of treatment), with medicines that are expensive and toxic, and higher rates of treatment failure and death [ 13 , 33 ]. Rapid diagnosis and accurate detection of all forms of drug-resistant tuberculosis is a key factor for effective patient care and for reducing and containing the spread of these resistant strains [ 34 ].…”

“…In Morocco, tuberculosis is endemic and a major public health problem and 36 000 cases of TB were notified in 2018, with nearly 150 new cases per 100 000 inhabitants [ 12 ]. The incidence rate of MDR/RIF R -TB was estimated to be 530 in the year 2018 compared to 160 patients in 2015 [ 13 ]. Despite the use of the directly observed treatment short-course strategy for controlling the disease since 1991, the incidence is still increasing, with an alarming increase in the number of MDR-TB with each passing year [ 14 ].…”

Efficacy of surgery via the single anterior and single posterior approaches for treatment of thoracic spinal tuberculosis

“…However, the incidence of TB has again been increasing with the emergence of drug-resistant M. tuberculosis strains, and this increased incidence is closely related to economic development and the nutritional environment. 2 China has a large population and unbalanced regional economic development. Statistics show that China ranks third in the incidence of TB worldwide.…”